Denali Therapeutics Inc (NASDAQ:DNLI)

30.43
Delayed Data
As of 4:00pm ET
 -1.09 / -3.46%
Today’s Change
20.76
Today|||52-Week Range
39.43
+9.42%
Year-to-Date
No recent news for Denali Therapeutics Inc.

Today’s Trading

Previous close31.52
Today’s open30.91
Day’s range30.35 - 31.57
Volume16,350
Average volume (3 months)721,999
Market cap$4.3B
Data as of 4:00pm ET, 06/05/2023

Growth & Valuation

Earnings growth (last year)-8.61%
Earnings growth (this year)-20.38%
Earnings growth (next 5 years)-11.13%
Revenue growth (last year)+122.90%
P/E ratioNM
Price/Sales32.19
Price/Book4.11

Competitors

----
HALOHalozyme Therapeutic...-0.52-1.55%
----
ARWRArrowhead Pharmaceut...-1.06-2.94%
Data as of 3:59pm ET, 06/05/2023

Financials

Next reporting dateAugust 2, 2023
EPS forecast (this quarter)-$0.58
Annual revenue (last year)$108.5M
Annual profit (last year)-$326.0M
Net profit margin-300.56%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
San Francisco, California

Forecasts